p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.
about
p53 regulation of G(2) checkpoint is retinoblastoma protein dependentPUMA mediates the apoptotic response to p53 in colorectal cancer cellsCore signaling pathways in human pancreatic cancers revealed by global genomic analysesDietary flavonoids and the MLL gene: A pathway to infant leukemia?Analysis of epidemiological cohort data on smoking effects and lung cancer with a multi-stage cancer modelClinical outcomes and correlates of TP53 mutations and cancer.Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study.TP53 mutations in Korean patients with non-small cell lung cancer.Role of p53 serine 46 in p53 target gene regulation.Carcinogenesis in mouse and human cells: parallels and paradoxes.Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer riskCalcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors.Alcohol consumption and rectal tumor mutations and epigenetic changes.Reduced rates of gene loss, gene silencing, and gene mutation in Dnmt1-deficient embryonic stem cells.Mechanisms of cell-cycle checkpoints: at the crossroads of carcinogenesis and drug discovery.Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, contribute to risk of cutaneous melanoma.p53 as a mutagen test in breast cancer.Household income is associated with the p53 mutation frequency in human breast tumorsLikelihood models of somatic mutation and codon substitution in cancer genes.Significance of TP53 mutations in human cancer: a critical analysis of mutations at CpG dinucleotides.Genetic polymorphisms of multiple DNA repair pathways impact age at diagnosis and TP53 mutations in breast cancer.Evidence for activation of mutated p53 by apigenin in human pancreatic cancer.Down-regulation of nitric oxide synthase-2 and cyclooxygenase-2 pathways by p53 in squamous cell carcinoma.Genetic pathways and mutation profiles of human cancers: site- and exposure-specific patternsMethylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement.Study of p53 gene alteration as a biomarker to evaluate the malignant risk of Lugol-unstained lesion with non-dysplasia in the oesophagus.NAT10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2.Pathological features and genetic alterations in colorectal carcinomas with characteristics of nonpolypoid growthp53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.Cytosine methylation effects on the repair of O6-methylguanines within CG dinucleotides.Tumor markers and rectal cancer: support for an inflammation-related pathway.Is there a specific mutation of p53 gene due to radon exposure? A systematic review.APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidaseMapping structurally defined guanine oxidation products along DNA duplexes: influence of local sequence context and endogenous cytosine methylationDistinct roles of Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer.Specific interaction of p53 with target binding sites is determined by DNA conformation and is regulated by the C-terminal domain.Chromosomal numerical abnormalities in early stage lung adenocarcinoma.Molecular fingerprints of environmental carcinogens in human cancer.The NAD(+) salvage pathway modulates cancer cell viability via p73.Clinical Outcomes of TP53 Mutations in Cancers.
P2860
Q22254140-B8F03015-6212-44D1-84E0-93B0423B0214Q24550772-0588E50B-6CAF-490A-B6AD-3FAF77BEB335Q24606006-D81F0278-1219-4AF6-9A34-11D873DE30AFQ24609631-ED268DBF-AC1D-4945-8E6C-8029265AAC47Q31029639-C5C2EDE2-1E8B-410D-9FCC-3B283B0717E0Q33693838-F5952B9E-854F-4DC9-A104-4D7D936497ABQ33784787-4A7CB9ED-A7EC-4D38-8FFA-A8EC5CC167A8Q33807219-F272F64A-3A7E-4A02-9327-9048C7147FF4Q33843352-5A983435-F60D-4493-B67B-72C42D90B0FEQ33846175-0EDFCD46-C817-4177-89B9-56ECDA2C4703Q33905119-0001D999-8745-43A3-AFAB-5789FC8BC0A1Q33954687-F09AF19C-1096-4AEC-B8C5-23968FF4518FQ34007796-7A60F67B-6DF2-47AE-B352-8E8701F1F54FQ34012712-8EF68768-FC16-495E-BBF7-8314BEFC0A4DQ34119143-BBC521B5-546D-4160-B336-A335A5F4CF56Q34121882-149EAA67-79CD-4D30-8DD0-F70164E6D7BDQ34580735-4B54E23C-DBC3-4716-83AC-09C817FD3452Q34613059-840C0CB9-3672-423B-AB4D-C87040FEE846Q34618683-F316F735-4B2D-4D0B-BDED-8C97E33F8004Q35078721-80F355AF-3A18-4F92-BFCE-0FFD55F1AF62Q35190796-4D7A5285-32E9-413D-B2BD-E5ED9D265819Q35751608-0915DB24-3457-4645-85F2-E24B60078009Q35791826-110CA56B-DEAE-4DE0-920F-EE099FDFFDE2Q36253611-C7A96495-38F2-4C73-867F-6996224C1324Q36412573-C87DDC48-7AD7-41E4-A149-96E85CF12FD3Q36609832-91AA160E-B3F2-4A14-B795-A797EE5B8151Q36636154-80C1097A-1702-43FF-AC57-49A56CA30CA5Q36695306-4FB4DD3E-AB51-4541-BD42-14A9C945ECB4Q37010494-A7075CBB-54FD-48D4-83EF-1A575D39A66AQ37371614-82BBFE2C-EDC9-4932-A362-90D8B5016B57Q37401248-12DDE803-E3FC-463F-905B-6447E15B17A6Q37500150-F82E174D-58A2-4104-81C3-4AB47ED3594EQ37577458-E57F7FCF-3E17-4438-B268-A3CB6863607DQ37701731-81BDDCFD-0580-461E-97D7-79FEAF2CC1C3Q38115771-623632F3-902C-4382-8C29-41F8FD82090BQ38363728-08D9E697-E0E6-4D08-9C17-153011C9872EQ38438727-01B345B1-C223-4533-8627-645A7CBAD48EQ38507277-B1607855-58B6-4DBA-81D5-531BC8F8D983Q38818192-C4B43E61-F1E7-40C0-BA47-676A45A61E79Q38906201-DFFCBAF9-B406-43C4-BB94-DE3AFE766EA2
P2860
p53 mutation spectrum and load: the generation of hypotheses linking the exposure of endogenous or exogenous carcinogens to human cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
p53 mutation spectrum and load ...... s carcinogens to human cancer.
@ast
p53 mutation spectrum and load ...... s carcinogens to human cancer.
@en
type
label
p53 mutation spectrum and load ...... s carcinogens to human cancer.
@ast
p53 mutation spectrum and load ...... s carcinogens to human cancer.
@en
prefLabel
p53 mutation spectrum and load ...... s carcinogens to human cancer.
@ast
p53 mutation spectrum and load ...... s carcinogens to human cancer.
@en
P1433
P1476
p53 mutation spectrum and load ...... s carcinogens to human cancer.
@en
P2093
P356
10.1016/S1383-5742(99)00028-9
P407
P577
1999-07-01T00:00:00Z